Literature DB >> 19349310

A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.

Jens R Wendland1, Pablo R Moya, Kiara R Timpano, Adriana P Anavitarte, Matthew R Kruse, Michael G Wheaton, Renee F Ren-Patterson, Dennis L Murphy.   

Abstract

CONTEXT: Recent evidence from linkage analyses and follow-up candidate gene studies supports the involvement of SLC1A1, which encodes the neuronal glutamate transporter, in the development of obsessive-compulsive disorder (OCD).
OBJECTIVES: To determine the role of genetic variation of SLC1A1 in OCD in a large case-control study and to better understand how SLC1A1 variation affects functionality.
DESIGN: A case-control study.
SETTING: Publicly accessible SLC1A1 expression and genotype data. PATIENTS: Three hundred twenty-five OCD probands and 662 ethnically and sex-matched controls.
INTERVENTIONS: Probands were assessed with the Structured Clinical Interview for DSM-IV, the Yale-Brown Obsessive Compulsive Scale, and the Saving Inventory-Revised. Six single-nucleotide polymorphisms (SNPs) were genotyped. Multiple testing corrections for single-marker and haplotype analyses were performed by permutation.
RESULTS: Gene expression of SLC1A1 is heritable in lymphoblastoid cell lines. We identified 3 SNPs in or near SLC1A1 that correlated with gene expression levels, 1 of which had previously been associated with OCD. Two of these SNPs also predicted expression levels in human brain tissue, and 1 SNP was further functional in reporter gene studies. Two haplotypes at 3 SNPs, rs3087879, rs301430, and rs7858819, were significantly associated with OCD after multiple-testing correction and contained 2 SNPs associated with expression levels. In addition, another SNP correlating with SLC1A1 gene expression, rs3933331, was associated with an OCD-hoarding subphenotype as assessed by 2 independent, validated scales.
CONCLUSIONS: Our case-control data corroborate previous smaller family-based studies that indicated that SLC1A1 is a susceptibility locus for OCD. The expression and genotype database-mining approach we used provides a potentially useful complementary approach to strengthen future candidate gene studies in neuropsychiatric and other disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19349310      PMCID: PMC2775716          DOI: 10.1001/archgenpsychiatry.2009.6

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  49 in total

1.  Glutamatergic dysfunction in OCD.

Authors:  Kaushik Chakrabarty; Sagnik Bhattacharyya; Rita Christopher; Sumant Khanna
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

2.  Common genetic variants account for differences in gene expression among ethnic groups.

Authors:  Richard S Spielman; Laurel A Bastone; Joshua T Burdick; Michael Morley; Warren J Ewens; Vivian G Cheung
Journal:  Nat Genet       Date:  2007-01-07       Impact factor: 38.330

3.  Functional SLITRK1 var321, varCDfs and SLC6A4 G56A variants and susceptibility to obsessive-compulsive disorder.

Authors:  J R Wendland; M R Kruse; D L Murphy
Journal:  Mol Psychiatry       Date:  2006-09       Impact factor: 15.992

4.  WHAP: haplotype-based association analysis.

Authors:  Shaun Purcell; Mark J Daly; Pak C Sham
Journal:  Bioinformatics       Date:  2006-11-21       Impact factor: 6.937

5.  Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.

Authors:  Diane E Dickel; Jeremy Veenstra-VanderWeele; Nancy J Cox; Xiaolin Wu; Daniel J Fischer; Michelle Van Etten-Lee; Joseph A Himle; Bennett L Leventhal; Edwin H Cook; Gregory L Hanna
Journal:  Arch Gen Psychiatry       Date:  2006-07

6.  Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

Authors:  Paul Daniel Arnold; Tricia Sicard; Eliza Burroughs; Margaret A Richter; James L Kennedy
Journal:  Arch Gen Psychiatry       Date:  2006-07

7.  Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.

Authors:  K P Lesch; D Bengel; A Heils; S Z Sabol; B D Greenberg; S Petri; J Benjamin; C R Müller; D H Hamer; D L Murphy
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

8.  Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.

Authors:  Koji Aoyama; Sang Won Suh; Aaron M Hamby; Jialing Liu; Wai Yee Chan; Yongmei Chen; Raymond A Swanson
Journal:  Nat Neurosci       Date:  2005-11-27       Impact factor: 24.884

9.  Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity.

Authors:  Gregor Hasler; V Holland LaSalle-Ricci; Jonne G Ronquillo; Sarah A Crawley; Lauren W Cochran; Diane Kazuba; Benjamin D Greenberg; Dennis L Murphy
Journal:  Psychiatry Res       Date:  2005-06-15       Impact factor: 3.222

Review 10.  Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.

Authors:  Christopher Pittenger; John H Krystal; Vladimir Coric
Journal:  NeuroRx       Date:  2006-01
View more
  54 in total

1.  Family-based genetic association study of DLGAP3 in Tourette Syndrome.

Authors:  Jacquelyn Crane; Jesen Fagerness; Lisa Osiecki; Boyd Gunnell; S Evelyn Stewart; David L Pauls; Jeremiah M Scharf
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-02       Impact factor: 3.568

2.  Functional studies and rare variant screening of SLC1A1/EAAC1 in males with obsessive-compulsive disorder.

Authors:  Jeremy Veenstra-VanderWeele; Tim Xu; Alicia M Ruggiero; Lauren R Anderson; Shaine T Jones; Joseph A Himle; James L Kennedy; Margaret A Richter; Gregory L Hanna; Paul D Arnold
Journal:  Psychiatr Genet       Date:  2012-10       Impact factor: 2.458

3.  Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression.

Authors:  Claudia Delgado-Acevedo; Sebastián F Estay; Anna K Radke; Ayesha Sengupta; Angélica P Escobar; Francisca Henríquez-Belmar; Cristopher A Reyes; Valentina Haro-Acuña; Elías Utreras; Ramón Sotomayor-Zárate; Andrew Cho; Jens R Wendland; Ashok B Kulkarni; Andrew Holmes; Dennis L Murphy; Andrés E Chávez; Pablo R Moya
Journal:  Neuropsychopharmacology       Date:  2018-12-26       Impact factor: 7.853

Review 4.  Neuromodulation for obsessive-compulsive disorder.

Authors:  Kyle A B Lapidus; Emily R Stern; Heather A Berlin; Wayne K Goodman
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 5.  Learning From Animal Models of Obsessive-Compulsive Disorder.

Authors:  Patricia Monteiro; Guoping Feng
Journal:  Biol Psychiatry       Date:  2015-05-04       Impact factor: 13.382

6.  OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior.

Authors:  Isaac D Zike; Muhammad O Chohan; Jared M Kopelman; Emily N Krasnow; Daniel Flicker; Katherine M Nautiyal; Michael Bubser; Christoph Kellendonk; Carrie K Jones; Gregg Stanwood; Kenji Fransis Tanaka; Holly Moore; Susanne E Ahmari; Jeremy Veenstra-VanderWeele
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

Review 7.  Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.

Authors:  David L Pauls; Amitai Abramovitch; Scott L Rauch; Daniel A Geller
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

Review 8.  Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment.

Authors:  N A Fineberg; S R Chamberlain; E Hollander; V Boulougouris; T W Robbins
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 9.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

10.  Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study.

Authors:  Ke Wu; Gregory L Hanna; Philip Easter; James L Kennedy; David R Rosenberg; Paul D Arnold
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.